Abstract
Background
The high prevalence of gastroesophageal reflux disease continues to encourage the development of treatment modalities to fill the gap between acid-suppression therapy and the laparoscopic Nissen fundoplication. The Magnetic Sphincter Augmentation device has been designed to augment the lower esophageal sphincter barrier using magnetic force. A multi-center feasibility trial was done to evaluate safety and efficacy.
Methods
Patients with typical heartburn (at least partially responding to proton-pump inhibitors), abnormal esophageal acid exposure, and normal esophageal peristalsis were enrolled. Patients with hiatal hernia >3 cm were excluded from the study. The device was implanted laparoscopically around the distal esophagus.
Results
Over a 1-year period, 38 out of 41 enrolled patients underwent this procedure in 3 hospitals. No operative complications were recorded. A free diet was allowed since post-operative day one, and 97% of patients were discharged within 48 h. The mean follow-up was 209 days (range 12–434 days). The GERD-HRQL score decreased from 26.0 to 1.0 (p < 0.005). At 3 months post-operatively, 89% of patients were off anti-reflux medications, and 79% of patients had a normal 24-h pH test. All patients preserved the ability to belch. Mild dysphagia occurred in 45% of patients. No migrations or erosions of the device occurred.
Conclusions
Laparoscopic implant of the MSA device is safe and well tolerated. It requires minimal surgical dissection and a short learning curve compared to the conventional Nissen fundoplication.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Shaheen N, Hansen R, Morgan D, Gangarosa L, Ringel Y, Thiny M et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006;101:2128–2138. doi:10.1111/j.1572-0241.2006.00723.x.
El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007;5:17–26. doi:10.1016/j.cgh.2006.09.016.
Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–831. doi:10.1056/NEJM199903183401101.
Iqbal A, Salinas V, Filipi C. Endoscopic therapies of gastroesophageal reflux disease. World J Gastroenterol. 2006;12:2641–2655.
Shaheen N. The rise and fall (and rise?) of endoscopic antireflux procedures. Gastroenterology. 2006;131:952–954. doi:10.1053/j.gastro.2006.07.030.
Velanovich V. Comparison of generic (SF-36) vs disease-specific (GERD-HRQL) quality of life scales for gastroesophageal reflux disease. J Gastrointest Surg. 1998;2:141–145. doi:10.1016/S1091–255X(98)80004–8.
Streets C, DeMeester T. Ambulatory 24-hour esophageal pH monitoring. Why, when, and what to do. J Clin Gastroenterol. 2003;37:14–22. doi:10.1097/00004836–200307000–00007.
Peters J, DeMeester T, Crookes P, Oberg S, deVos Shoop M, Hagen J, Bremner C. The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication. A prospective evaluation of 100 patients with “typical” symptoms. Ann Surg 1998;228:40–50. doi:10.1097/00000658–199807000–00007.
Dallemagne B, Weerts J, Markiewicz S, Dewandre J, Wahlen C, Monami B et al. Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc. 2006;20:159–165. doi:10.1007/s00464–005–0174-x.
Oelschlager B, Quiroga E, Parra J, Cahill M, Polissar N, Pellegrini C. Long-term outcomes after laparoscopic antireflux surgery. Am J Gastroenterol 2007;102:1–8. doi:10.1111/j.1572–0241.2007.01057.x.
Kelly J, Watson D, Chin K, Devitt P, Game P, Jamieson G. Laparoscopic Nissen fundoplication: clinical outcomes at 10 years. J Am Coll Surg 2007;205:570–575. doi:10.1016/j.jamcollsurg.2007.05.024.
Morgenthal C, Shane M, Stval A, Gletsu N, Milam G, Swafford V et al. The durability of laparoscopic Nissen fundoplication: 11-year outcome. J Gastrointest Surg 2007;11:693–700. doi:10.1007/s11605–007–0161–8.
Hunter J, Smith C, Branum G, Waring J, Trus T, Cornwell M et al. Laparoscopic fundoplication failures: patterns of failure and response to fundoplication. Ann Surg 1999;230:595–606. doi:10.1097/00000658–199910000–00015.
Vakil N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic fundoplication in a US community. Am J Med 2003;114:1–5. doi:10.1016/S0002–9343(02)01390–6.
Finks J, Wei Y, Birkmeyer J. The rise and fall of antireflux surgery in the United States. Surg Endosc 2006;20:1698–1701. doi:10.1007/s00464–006–0042–3.
Ganz R, Gostout C, Grudem J, Swanson W, Berg T, DeMeester T. Use of a magnetic sphincter for the treatment of GERD: a feasibility study. Gastrointest Endosc 2008;67:287–294. doi:10.1016/j.gie.2007.07.027.
Kwok H, Marriz Y, Al-Ali S, Windsor J. Phrenoesophageal ligament re-visited. Clin Anat 1999;12:164–170. doi:10.1002/(SICI)1098–2353(1999)12:3<164::AID-CA4>3.0.CO;2-N.
DeMeester T, Wernly J, Bryant G, Little A, Skinner D. Clinical and in vitro analysis of gastroesophageal competence: a study of the principles of antireflux surgery. Am J Surg 1979;137:39–46. doi:10.1016/0002–9610(79)90008–4.
Bonavina L, DeMeester T, Mason R, Stein H, Feussner H, Evander A. Mechanical effect of the Angelchik prosthesis on the competency of the gastric cardia: pathophysiological implications and clinical perspectives. Dis Esophagus 1997;10:115–118.
Kahrilas P. Magnetic enhancement of the lower esophageal sphincter. Gastrointest Endosc. 2008;67:295–296. doi:10.1016/j.gie.2007.08.032.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bonavina, L., Saino, G.I., Bona, D. et al. Magnetic Augmentation of the Lower Esophageal Sphincter: Results of a Feasibility Clinical Trial. J Gastrointest Surg 12, 2133–2140 (2008). https://doi.org/10.1007/s11605-008-0698-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-008-0698-1